A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Healthy

Interventions

DRUG

MK-1708

MK-1708 oral suspension

DRUG

Placebo

Placebo oral suspension

Trial Locations (1)

Velocity Clinical Research, Hallandale Beach ( Site 0001), Hallandale

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06647628 - A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005) | Biotech Hunter | Biotech Hunter